$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923023568 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$5.134M	$5.568M	$5.034M
YoY Change	6.34%	10.61%	12.47%
Cost Of Revenue	$3.032M	$3.050M	$2.946M
YoY Change	5.61%	3.53%	2.68%
Gross Profit	$2.102M	$2.518M	$2.088M
YoY Change	7.41%	20.59%	29.93%
Gross Profit Margin	40.94%	45.22%	41.48%
Selling, General & Admin	$1.735M	$1.988M	$1.146M
YoY Change	37.7%	73.47%	5.14%
% of Gross Profit	82.54%	78.95%	54.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.265M	$1.242M	$1.163M
YoY Change	7.02%	6.79%	-9.0%
% of Gross Profit	60.18%	49.32%	55.7%
Operating Expenses	$1.735M	$1.988M	$1.146M
YoY Change	37.7%	73.47%	5.14%
Operating Profit	$90.00K	-$325.0K	$793.0K
YoY Change	-79.91%	-140.98%	125.28%
Interest Expense	$277.0K	$277.0K	$149.0K
YoY Change	11.24%	85.91%	-9.7%
% of Operating Profit	307.78%		18.79%
Other Income/Expense, Net
YoY Change
Pretax Income	$225.0K	-$212.0K	$788.0K
YoY Change	-53.51%	-126.9%	-1645.1%
Income Tax	$60.00K	-$35.00K	$248.0K
% Of Pretax Income	26.67%		31.47%
Net Earnings	$118.0K	-$111.0K	$497.0K
YoY Change	-62.66%	-122.33%	-671.26%
Net Earnings / Revenue	2.3%	-1.99%	9.87%
Basic Earnings Per Share	$0.02	-$0.02	$0.08
Diluted Earnings Per Share	$0.02	-$0.02	$0.08
COMMON SHARES
Basic Shares Outstanding	6.244M	6.214M	6.203M
Diluted Shares Outstanding	6.432M	6.336M	6.281M

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.54M	$13.68M	$11.85M
YoY Change	25.93%	15.42%	42.43%
Cash & Equivalents	$14.54M	$13.68M	$11.85M
Short-Term Investments
Other Short-Term Assets	$1.200M	$1.081M	$885.0K
YoY Change	4.35%	22.15%	-4.32%
Inventory
Prepaid Expenses
Receivables	$3.986M	$4.690M	$3.363M
Other Receivables	$651.0K	$636.0K	$743.0K
Total Short-Term Assets	$20.37M	$20.08M	$16.84M
YoY Change	21.05%	19.26%	25.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.29M	$22.99M	$26.27M
YoY Change	0.56%	-12.48%	-12.76%
Goodwill	$1.265M	$1.265M	$1.265M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$78.00K	$78.00K	$78.00K
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments
YoY Change
Other Assets	$353.0K	$38.00K	$70.00K
YoY Change	301.14%	-45.71%	-6.67%
Total Long-Term Assets	$26.99M	$24.37M	$27.69M
YoY Change	1.53%	-11.96%	-12.21%
TOTAL ASSETS
Total Short-Term Assets	$20.37M	$20.08M	$16.84M
Total Long-Term Assets	$26.99M	$24.37M	$27.69M
Total Assets	$47.36M	$44.46M	$44.53M
YoY Change	9.1%	-0.15%	-1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$346.0K	$297.0K	$145.0K
YoY Change	28.15%	104.83%	-75.17%
Accrued Expenses	$2.810M	$2.275M	$1.898M
YoY Change	48.83%	19.86%	-30.83%
Deferred Revenue		$554.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.459M	$1.264M	$1.641M
YoY Change	15.61%	-22.97%	83.76%
Total Short-Term Liabilities	$10.05M	$6.756M	$4.630M
YoY Change	135.67%	45.92%	-10.38%
LONG-TERM LIABILITIES
Long-Term Debt	$10.45M	$11.08M	$13.50M
YoY Change	-17.14%	-17.94%	-10.86%
Other Long-Term Liabilities	$30.00K	$58.00K	$258.0K
YoY Change	-83.43%	-77.52%	-57.07%
Total Long-Term Liabilities	$10.45M	$11.08M	$13.50M
YoY Change	-17.14%	-17.94%	-10.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.05M	$6.756M	$4.630M
Total Long-Term Liabilities	$10.45M	$11.08M	$13.50M
Total Liabilities	$21.35M	$18.72M	$19.19M
YoY Change	18.75%	-2.46%	-5.54%
SHAREHOLDERS EQUITY
Retained Earnings	$3.214M	$3.096M	$2.457M
YoY Change	15.9%	26.01%	70.74%
Common Stock	$18.90M	$18.80M	$18.37M
YoY Change	2.47%	2.36%	2.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.11M	$21.90M	$20.82M
YoY Change
Total Liabilities & Shareholders Equity	$47.36M	$44.46M	$44.53M
YoY Change	9.1%	-0.15%	-1.02%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$118.0K	-$111.0K	$497.0K
YoY Change	-62.66%	-122.33%	-671.26%
Depreciation, Depletion And Amortization	$1.265M	$1.242M	$1.163M
YoY Change	7.02%	6.79%	-9.0%
Cash From Operating Activities	$3.570M	$3.453M	$3.833M
YoY Change	131.67%	-9.91%	267.15%
INVESTING ACTIVITIES
Capital Expenditures	$3.620M	$2.352M	-$30.00K
YoY Change	-1633.9%	-7940.0%	-103.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.620M	-$2.352M	-$30.00K
YoY Change	1433.9%	7740.0%	-103.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	910.0K	-508.0K	-237.0K
YoY Change	-156.59%	114.35%	-115.35%
NET CHANGE
Cash From Operating Activities	3.570M	3.453M	3.833M
Cash From Investing Activities	-3.620M	-2.352M	-30.00K
Cash From Financing Activities	910.0K	-508.0K	-237.0K
Net Change In Cash	860.0K	593.0K	3.566M
YoY Change	-383.83%	-83.37%	4.15%
FREE CASH FLOW
Cash From Operating Activities	$3.570M	$3.453M	$3.833M
Capital Expenditures	$3.620M	$2.352M	-$30.00K
Free Cash Flow	-$50.00K	$1.101M	$3.863M
YoY Change	-102.81%	-71.5%	1757.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6214000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6184000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6184000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	19000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-08789
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-2918118
	dei	Entity Address Address Line1 EntityAddressAddressLine1	601 Montgomery Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94111-2619
	dei	City Area Code CityAreaCode	415
	dei	Local Phone Number LocalPhoneNumber	788-5300
	dei	Security12b Title Security12bTitle	American Shared Hospital Services Common Stock, No Par Value
	dei	Trading Symbol TradingSymbol	AMS
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6244000
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13676000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12335000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	118000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4690000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3801000	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	636000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	327000	usd
CY2023Q2	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	350000	usd
CY2022Q4	ams	Prepaid Maintenance Current PrepaidMaintenanceCurrent	1245000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	613000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	897000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	20083000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	18723000	usd
CY2023Q2	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	22828000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q2	us-gaap	Land Land	19000	usd
CY2022Q4	us-gaap	Land Land	19000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	1265000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1265000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	146000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	317000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	78000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	38000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87000	usd
CY2023Q2	us-gaap	Assets Assets	44457000	usd
CY2022Q4	us-gaap	Assets Assets	43956000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	297000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	752000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	735000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1396000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q2	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	938000	usd
CY2022Q4	ams	Asset Retirement Obligation Related Party Current AssetRetirementObligationRelatedPartyCurrent	360000	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	275000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	255000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	554000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	127000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	292000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1264000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1262000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6756000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5175000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	59000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11080000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12205000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	35000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	70000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	822000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	18716000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18331000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10763000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8036000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7843000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3096000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3019000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	21895000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21625000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	3846000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25741000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44457000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43956000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5568000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5034000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10493000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9881000	usd
CY2023Q2	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	505000	usd
CY2022Q2	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	462000	usd
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	991000	usd
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	902000	usd
CY2023Q2	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1227000	usd
CY2022Q2	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	1156000	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2584000	usd
	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2343000	usd
CY2023Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1023000	usd
CY2022Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1049000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1902000	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1933000	usd
CY2023Q2	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	295000	usd
CY2022Q2	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	279000	usd
	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	590000	usd
	ams	Other Cost Of Operating Revenue Related Party OtherCostOfOperatingRevenueRelatedParty	548000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	3050000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2946000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6067000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5726000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	2518000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2088000	usd
	us-gaap	Gross Profit GrossProfit	4426000	usd
	us-gaap	Gross Profit GrossProfit	4155000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1988000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1146000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3527000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2465000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	277000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	149000	usd
	us-gaap	Interest Expense InterestExpense	548000	usd
	us-gaap	Interest Expense InterestExpense	297000	usd
CY2023Q2	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
CY2022Q2	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-325000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	793000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-227000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1393000	usd
CY2023Q2	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	113000	usd
CY2022Q2	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	-5000	usd
	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	183000	usd
	ams	Interest And Other Income Loss InterestAndOtherIncomeLoss	-5000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-212000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	788000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-44000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1388000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-35000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	248000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	454000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-177000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	540000	usd
	us-gaap	Profit Loss ProfitLoss	-77000	usd
	us-gaap	Profit Loss ProfitLoss	934000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-66000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-154000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	168000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-111000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	497000	usd
	us-gaap	Net Income Loss NetIncomeLoss	77000	usd
	us-gaap	Net Income Loss NetIncomeLoss	766000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6203000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6187000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6336000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6281000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6465000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6266000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24239000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	87000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	394000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24720000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	72000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	540000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25337000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25625000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	96000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	100000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25821000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	97000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-177000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25741000	usd
	us-gaap	Profit Loss ProfitLoss	-77000	usd
	us-gaap	Profit Loss ProfitLoss	934000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2609000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2375000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
	ams	Noncash Lease Expense NoncashLeaseExpense	171000	usd
	ams	Noncash Lease Expense NoncashLeaseExpense	168000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	319000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	193000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	159000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	18000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1187000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-718000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1230000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1261000	usd
	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	578000	usd
	ams	Increase Decrease In Asset Retirement Obligations Related Party IncreaseDecreaseInAssetRetirementObligationsRelatedParty	-457000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	656000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-792000	usd
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	627000	usd
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-446000	usd
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-206000	usd
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-202000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5214000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4092000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2561000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	96000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2561000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1160000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	297000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	152000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1312000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-292000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1341000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3704000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12453000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8263000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13794000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11967000	usd
	us-gaap	Interest Paid Net InterestPaidNet	507000	usd
	us-gaap	Interest Paid Net InterestPaidNet	260000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	229000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	156000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13676000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11849000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	118000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13794000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11967000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5568000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5034000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10493000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9881000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-111000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	497000	usd
	us-gaap	Net Income Loss NetIncomeLoss	77000	usd
	us-gaap	Net Income Loss NetIncomeLoss	766000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<b>Reclassification</b> - Certain comparative balances as of and for the <em style="font: inherit;">three</em> and <em style="font: inherit;">six</em>-month periods ended <em style="font: inherit;"> June 30, 2022</em> have been reclassified to make them consistent with the current period presentation.
CY2023Q2	us-gaap	Depreciation Depreciation	1242000	usd
	us-gaap	Depreciation Depreciation	2609000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	1163000	usd
	us-gaap	Depreciation Depreciation	2375000	usd
CY2023Q2	ams	Write Down Of Impaired Assets And Associated Removal Costs WriteDownOfImpairedAssetsAndAssociatedRemovalCosts	578000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	76195000	usd
CY2022Q4	ams	Property Plant And Equipment Gross Excluding Land PropertyPlantAndEquipmentGrossExcludingLand	74237000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	53367000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50770000	usd
CY2023Q2	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	22828000	usd
CY2022Q4	ams	Property Plant And Equipment Net Excluding Land PropertyPlantAndEquipmentNetExcludingLand	23467000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	19000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	162000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	198000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	12344000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	162000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	485000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2094000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2469000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7294000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	164000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	12506000	usd
CY2023Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	135000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	591000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	323000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	92000	usd
CY2023Q2	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	624000	usd
CY2022Q4	ams	Accrued Operating Costs Current AccruedOperatingCostsCurrent	539000	usd
CY2023Q2	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	314000	usd
CY2022Q4	ams	Accrued Liabilites Other Current AccruedLiabilitesOtherCurrent	322000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1396000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1544000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	146000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	150000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	95000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	59000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	154000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	150000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	103000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	101000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	206000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	202000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	49000	usd
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	43000	usd
	us-gaap	Sublease Income SubleaseIncome	99000	usd
	us-gaap	Sublease Income SubleaseIncome	86000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	54000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	58000	usd
	us-gaap	Lease Cost LeaseCost	107000	usd
	us-gaap	Lease Cost LeaseCost	116000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	103000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	101000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	206000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	202000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M1D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M7D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M1D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M7D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0528	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0575	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0528	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0575	pure
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-111000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	497000	usd
	us-gaap	Net Income Loss NetIncomeLoss	77000	usd
	us-gaap	Net Income Loss NetIncomeLoss	766000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6203000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6336000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6187000
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	78000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	129000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	79000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6336000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6281000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6465000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6266000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	95000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.82
CY2023Q1	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P7Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.69
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	146000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.80
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	20000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.92
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	67000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.58
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	58000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M14D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	50000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.74
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y11M26D

Files In Submission

Name	View Source	Status
0001437749-23-023568-index-headers.html	Edgar Link	pending
0001437749-23-023568-index.html	Edgar Link	pending
0001437749-23-023568.txt	Edgar Link	pending
0001437749-23-023568-xbrl.zip	Edgar Link	pending
ams-20230630.xsd	Edgar Link	pending
asha20230630_10q.htm	Edgar Link	pending
ex_534546.htm	Edgar Link	pending
ex_534549.htm	Edgar Link	pending
ex_534550.htm	Edgar Link	pending
ex_534551.htm	Edgar Link	pending
ex_558409.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
h01.jpg	Edgar Link	pending
h02.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
ams-20230630_cal.xml	Edgar Link	unprocessable
ams-20230630_pre.xml	Edgar Link	unprocessable
ams-20230630_lab.xml	Edgar Link	unprocessable
ams-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
asha20230630_10q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q3 Form 10-Q Financial Statement

#000143774923023568 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2023 Q3 Form 10-Q Financial Statement

#000143774923023568 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams